XOM
48
3
HCA
57
2
USB
46
9
FITB
50
2
TSCO
55
-2
PYPL
37
-4
VIX
33
3
ABBV
70
2
CPB
44
4
AES
54
3
AKAM
45
-2
SCHW
52
3
MCHP
49
-3
DHI
60
12
EQR
67
2
BA
45
3
ACN
42
-16
CMA
40
3
QCOM
72
-5
TGT
45
3
XOM
48
3
HCA
57
2
USB
46
9
FITB
50
2
TSCO
55
-2
PYPL
37
-4
VIX
33
3
ABBV
70
2
CPB
44
4
AES
54
3
AKAM
45
-2
SCHW
52
3
MCHP
49
-3
DHI
60
12
EQR
67
2
BA
45
3
ACN
42
-16
CMA
40
3
QCOM
72
-5
TGT
45
3
Financhill
Back

Arcus Biosciences 10K Form

Buy
55

RCUS
Arcus Biosciences

Last Price:
15.85
Seasonality Move:
-2.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RCUS News And Ratings

See the #1 stock for the next 7 days that we like better than RCUS

RCUS Financial Statistics

Sales & Book Value

Annual Sales: $117M
Cash Flow: $-6M
Price / Cash Flow: 0
Annual Sales: $7.78
Price / Book: 2.11

Profitability

EPS (TTM): -3.11000
Net Income (TTM): $-231M
Gross Margin: --
Return on Equity: -40.46%
Return on Assets: -19.08%

Arcus Biosciences Earnings Forecast

Key Arcus Biosciences Financial Ratios

  • The Research & Development expenses have been 290.60% of Revenue.
  • The Interest Expense is -0.65% of Operating Income.
  • The Net Earning history of RCUS is -262.39% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 1 years.

Arcus Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: RCUS
CUSIP: 03969F
Website: arcusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.22
Quick Ratio: 5.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RCUS Technical Analysis vs Fundamental Analysis

Buy
55
Arcus Biosciences (RCUS) is a Buy

Is Arcus Biosciences a Buy or a Sell?

  • Arcus Biosciences stock is rated a Buy
    The current Arcus Biosciences [RCUS] share price is $16.41. The Score for RCUS is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.